Literature DB >> 10073795

Plasma platelet-activating factor acetylhydrolase activity is not associated with premature coronary atherosclerosis.

R V Shohet1, A Anwar, J M Johnston, J C Cohen.   

Abstract

Platelet-activating factor acetylhydrolase activity in plasma was compared between 72 subjects with angiographically normal coronary arteries and matched controls with clinically significant obstruction. No difference was seen, and we conclude that variation in plasma platelet-activating factor acetylhydrolase activity is not a risk factor for coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10073795     DOI: 10.1016/s0002-9149(98)00791-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

Review 1.  Predicting the risk of cardiovascular disease: where does lipoprotein-associated phospholipase A(2) fit in?

Authors:  Natalie Khuseyinova; Wolfgang Koenig
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

2.  Plasma lipoprotein-associated phospholipase A2 in patients with metabolic syndrome and carotid atherosclerosis.

Authors:  Hui-Ping Gong; Yi-Meng Du; Li-Na Zhong; Zhao-Qiang Dong; Xin Wang; Yong-Jun Mao; Qing-Hua Lu
Journal:  Lipids Health Dis       Date:  2011-01-19       Impact factor: 3.876

3.  Association of lipoprotein-associated phospholipase A2 mass with asymptomatic cerebral artery stenosis.

Authors:  Youxin Wang; Bin Zhou; Pingan Zhou; Yan Yao; Qinghua Cui; Yingping Liu; Jichun Yang; Shouling Wu; Xingquan Zhao; Yong Zhou
Journal:  J Cell Mol Med       Date:  2018-02-09       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.